Hydration Pharmaceuticals Company Ltd has released a press release.
FY23 Appendix 4E
Filed with ASX ·
On 6ix: 6ix.com/news/fy23-appendix-4e-18
6ix hasn’t read this filing yet.
Hydration Pharmaceuticals Company Limited on 6ix
Story so far
Earlier from Hydration Pharmaceuticals
- Q4 FY23 Quarterly Activities Report (App 4C)
- Q3 FY23 Quarterly Activities Report (App 4C)
- July Trading Update
- FY23 Half Year Results Announcement
- Appendix 4D and FY23 Half Year Financial Report
Later from Hydration Pharmaceuticals
- Variation to Facility Agreement with PURE Asset Management
- Waiver of ASX Listing Rule 10.1 Granted
- Q1 FY24 Quarterly Activities Report (App 4C)
- Q2 FY24 Quarterly Activities Report (App 4C)
- Appendix 4D and FY24 Half Year Financial Report
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals